JNJ Today - Aug 12: Stock Stays Flat Amid Buzz
Impossibile aggiungere al carrello
Puoi avere soltanto 50 titoli nel carrello per il checkout.
Riprova più tardi
Riprova più tardi
Rimozione dalla Lista desideri non riuscita.
Riprova più tardi
Non è stato possibile aggiungere il titolo alla Libreria
Per favore riprova
Non è stato possibile seguire il Podcast
Per favore riprova
Esecuzione del comando Non seguire più non riuscita
JNJ Today - Aug 12: Stock Stays Flat Amid Buzz
-
Letto da:
-
Di:
So, what went down? JNJ opened up and then just sorta hung around. No big swings, no crazy drama. It’s like that friend who shows up to the party but just stands by the snack table. The volume was right on point with its average, so people were trading like usual, but nobody was making any wild moves.
Now, why did JNJ stay so chill? Well, there’s a lot of chatter about the company hitting that massive $100 billion revenue mark soon, which is super exciting! But with all that buzz, folks are still debating whether the stock is worth grabbing right now. Some articles even mention it's nearing a 52-week high, which can make investors think twice before diving in. Plus, there’s news about JNJ advancing its Seltorexant treatment for major depressive disorder, which is a big deal. But again, no one really knows what that means for the stock today.
One thing worth noting is that Annex Advisory Services sold over 5,000 shares. That’s a decent chunk, and it could make some investors raise an eyebrow. It’s always interesting when you see big players making moves.
So, yeah, the stock kinda just sat there today. JNJ’s got some exciting stuff on the horizon, but today was just a slow bleed. As always, just remember this is all for fun and info, not advice. Catch you later!
adbl_web_anon_alc_button_suppression_t1
Ancora nessuna recensione